122 related articles for article (PubMed ID: 2447403)
21. Efficacy of epanolol versus metoprolol in angina pectoris: report from a Swedish multicentre study of exercise tolerance.
Rydén L
J Intern Med; 1992 Jan; 231(1):7-11. PubMed ID: 1346268
[TBL] [Abstract][Full Text] [Related]
22. Acute systemic and antiischemic effects of epanolol in patients with coronary artery disease.
Venneker EH; Remme WJ; van Hoogenhuyze DC; Krauss XH; Bartels GL; Kruijssen DA; Storm CJ; van Schelven D
Cardiovasc Drugs Ther; 1994 Apr; 8(2):211-9. PubMed ID: 7918133
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
24. Selectivity of the intrinsic sympathomimetic activity of the beta-adrenergic blocking drug bucindolol.
Leff AR; Garrity ER; Munoz NM; Tallet J; Cavigelli M; Deitchman D; Rajfer SI
J Cardiovasc Pharmacol; 1984; 6(5):859-66. PubMed ID: 6209492
[TBL] [Abstract][Full Text] [Related]
25. Influence of beta blockade and intrinsic sympathomimetic activity on hemodynamics, inotropy and respiration at rest and during exercise.
Sundberg S; Gordin A
Am J Cardiol; 1986 Jun; 57(15):1394-9. PubMed ID: 2872795
[TBL] [Abstract][Full Text] [Related]
26. Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.
Hombach V; Braun V; Höpp HW; Gil-Sanchez D; Behrenbeck DW; Tauchert M; Hilger HH
Br J Clin Pharmacol; 1982; 13(Suppl 2):285S-293S. PubMed ID: 6125178
[TBL] [Abstract][Full Text] [Related]
27. Relationship between beta adrenoceptor occupancy and receptor down-regulation induced by beta antagonists with intrinsic sympathomimetic activity.
Lima JJ
J Recept Signal Transduct Res; 1996; 16(5-6):357-72. PubMed ID: 8968966
[TBL] [Abstract][Full Text] [Related]
28. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Antonaccio MJ; High J; DeForrest JM; Sybertz E
J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
[TBL] [Abstract][Full Text] [Related]
29. Cardiac effects of beta-adrenoceptor blockade with intrinsic sympathomimetic activity during submaximal exercise.
Ades PA
Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):29S-33S. PubMed ID: 2894223
[TBL] [Abstract][Full Text] [Related]
30. Effects on physical performance of intrinsic sympathomimetic activity (ISA) during selective beta 1-blockade.
Kullmer T; Kindermann W; Singer M
Eur J Appl Physiol Occup Physiol; 1987; 56(3):292-8. PubMed ID: 2883003
[TBL] [Abstract][Full Text] [Related]
31. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
32. Cardiac safety of acute beta blockade: intrinsic sympathomimetic activity is superior to beta-1 selectivity.
Heikkilä J; Nieminen MS
Am Heart J; 1982 Aug; 104(2 Pt 2):464-72. PubMed ID: 7102533
[TBL] [Abstract][Full Text] [Related]
33. [Comparative studies of antihypertensive effects of several beta-blocking agents in conscious rats (author's transl)].
Ozawa H; Watanabe H; Chen CS
Nihon Yakurigaku Zasshi; 1978 Jan; 74(1):139-44. PubMed ID: 25230
[TBL] [Abstract][Full Text] [Related]
34. Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity.
Thulesius O; Gjöres JE; Berlin E
Br J Clin Pharmacol; 1982; 13(Suppl 2):229S-230S. PubMed ID: 6125174
[TBL] [Abstract][Full Text] [Related]
35. Effect of propranolol and pindolol on the up-regulation of lymphocytic beta adrenoceptors during acute submaximal physical exercise. A placebo-controlled double-blind study.
Mäki T; Näveri H; Leinonen H; Sovijärvi A; Lewko B; Härkönen M; Kontula K
J Cardiovasc Pharmacol; 1990 Apr; 15(4):544-51. PubMed ID: 1691382
[TBL] [Abstract][Full Text] [Related]
36. The effect of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on circadian heart rate.
Fitscha P; Tiso B; Meisner W; Spitzer D
Br J Clin Pharmacol; 1982; 13(Suppl 2):211S-215S. PubMed ID: 6125172
[TBL] [Abstract][Full Text] [Related]
37. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
Manyari DE; Kostuk WJ; Carruthers SG; Johnston DJ; Purves P
Am J Cardiol; 1983 Feb; 51(3):427-33. PubMed ID: 6401908
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
[TBL] [Abstract][Full Text] [Related]
39. Effect of beta-adrenoceptor blockade on renin-aldosterone and alpha-ANF during exercise at altitude.
Bouissou P; Richalet JP; Galen FX; Lartigue M; Larmignat P; Devaux F; Dubray C; Keromes A
J Appl Physiol (1985); 1989 Jul; 67(1):141-6. PubMed ID: 2527226
[TBL] [Abstract][Full Text] [Related]
40. Effect of beta blockade and intrinsic sympathomimetic activity on exercise performance.
Ades PA; Brammell HL; Greenberg JH; Horwitz LD
Am J Cardiol; 1984 Dec; 54(10):1337-41. PubMed ID: 6507309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
